Health care consultant discusses controversial Alzheimer’s drug

Health & Fitness

Two U.S. health systems will not be administering a controversial new Alzheimer’s drug to patients.

Health benefits expert Paul Seegert of PCS Advisers joined Pedro to talk about Adulhelm, and why many providers are refusing to cover it.

Copyright 2021 Nexstar Media Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.

Don't miss

More Featured

Latest News

More News